AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2016
Mar 17, 2016
35066_dirs_2016-03-17_3073380d-1825-45e2-a965-0f5899bb13a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2016-03-15
Reporting Person: WILCOX GARY (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-15 | Common Stock | P | 49020 | $0.51 | Acquired | 16938605 | Direct |
More from Cocrystal Pharma, Inc.
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19